Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Approbation of the Cancer Treatment Approach Based on the Eradication of TAMRA+ Cancer Stem Cells in a Model of Murine Cyclophosphamide Resistant Lymphosarcoma.

Kisaretova PE, Kirikovich SS, Ritter GS, Efremov YR, Taranov OS, Dubatolova TD, Proskurina AS, Potter EA, Dolgova EV, Sidorov SV, Ostanin AA, Chernykh ER, Bogachev SS.

Anticancer Res. 2020 Feb;40(2):795-805. doi: 10.21873/anticanres.14011. Erratum in: Anticancer Res. 2020 Mar;40(3):1787.

PMID:
32014922
2.

Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells.

Romanenko MV, Dolgova EV, Osipov ID, Ritter GS, Sizova MS, Proskurina AS, Efremov YR, Bayborodin SI, Potter EA, Taranov OS, Omigov VV, Kochneva GV, Grazhdantseva AA, Zavyalov EL, Razumov IA, Netesov SV, Bogachev SS.

Anticancer Res. 2019 Nov;39(11):6073-6086. doi: 10.21873/anticanres.13815.

PMID:
31704835
3.

Features of monocyte-derived dendritic cells encompassing a rare subpopulation of cells that are capable of natural internalization of extracellular dsDNA.

Proskurina AS, Spaselnikova AV, Ritter GS, Dolgova EV, Potter EA, Romanenko MV, Netesov SV, Efremov YR, Taranov OS, Varaksin NA, Ryabicheva TG, Ostanin AA, Chernykh ER, Bogachev SS.

Eur Cytokine Netw. 2019 Jun 1;30(2):43-58. doi: 10.1684/ecn.2019.0427.

PMID:
31486403
4.

Double-Stranded DNA Fragments Bearing Unrepairable Lesions and Their Internalization into Mouse Krebs-2 Carcinoma Cells.

Dolgova EV, Evdokimov AN, Proskurina AS, Efremov YR, Bayborodin SI, Potter EA, Popov AA, Petruseva IO, Lavrik OI, Bogachev SS.

Nucleic Acid Ther. 2019 Oct;29(5):278-290. doi: 10.1089/nat.2019.0786. Epub 2019 Jun 13.

PMID:
31194620
5.

Identification of the xenograft and its ascendant sphere-forming cell line as belonging to EBV-induced lymphoma, and characterization of the status of sphere-forming cells.

Dolgova EV, Petrova DD, Proskurina AS, Ritter GS, Kisaretova PE, Potter EA, Efremov YR, Bayborodin SI, Karamysheva TV, Romanenko MV, Netesov SV, Taranov OS, Ostanin AA, Chernykh ER, Bogachev SS.

Cancer Cell Int. 2019 May 6;19:120. doi: 10.1186/s12935-019-0842-x. eCollection 2019.

6.

Ultrastructural analysis of the Krebs-2 ascites cancer cells treated with extracellular double-stranded DNA preparation.

Kirikovich SS, Taranov OS, Omigov VV, Potter EA, Dolgova EV, Proskurina AS, Efremov YR, Bogachev SS.

Ultrastruct Pathol. 2019;43(1):56-65. doi: 10.1080/01913123.2019.1575499. Epub 2019 Feb 13.

PMID:
30758240
7.

Cancer Stem Cells: Emergent Nature of Tumor Emergency.

Efremov YR, Proskurina AS, Potter EA, Dolgova EV, Efremova OV, Taranov OS, Ostanin AA, Chernykh ER, Kolchanov NA, Bogachev SS.

Front Genet. 2018 Nov 16;9:544. doi: 10.3389/fgene.2018.00544. eCollection 2018.

8.

Efficacy of a new cancer treatment strategy based on eradication of tumor-initiating stem cells in a mouse model of Krebs-2 solid adenocarcinoma.

Potter EA, Proskurina AS, Ritter GS, Dolgova EV, Nikolin VP, Popova NA, Taranov OS, Efremov YR, Bayborodin SI, Ostanin AA, Chernykh ER, Kolchanov NA, Bogachev SS.

Oncotarget. 2018 Jun 19;9(47):28486-28499. doi: 10.18632/oncotarget.25503. eCollection 2018 Jun 19.

9.

Defective Dendritic Cell Cytotoxic Activity of High-Grade Glioma Patients' Results from the Low Expression of Membrane TNFα and Can Be Corrected In Vitro by Treatment with Recombinant IL-2 or Exogenic Double-Stranded DNA.

Tyrinova T, Leplina O, Mishinov S, Tikhonova M, Kalinovskiy A, Chernov S, Dolgova E, Stupak V, Voronina E, Bogachev S, Shevela E, Ostanin A, Chernykh E.

J Interferon Cytokine Res. 2018 Jul;38(7):298-310. doi: 10.1089/jir.2017.0084. Epub 2018 Jun 22.

PMID:
29932796
10.

Effect of Various Treatment Modes of Experimental Mammary Gland Tumor on Structure of Anterior Mediastinal Lymph Nodes.

Kazakov OV, Kabakov AV, Poveshchenko AF, Raiter TV, Strunkin DN, Bogachev SS, Ishchenko IY, Lykov AP, Michurina SV, Konenkov VI.

Bull Exp Biol Med. 2018 Mar;164(5):661-665. doi: 10.1007/s10517-018-4054-5. Epub 2018 Mar 26.

PMID:
29577189
11.

Novel Cancer Stem Marker and Its Applicability for Grading Primary Human Gliomas.

Dolgova EV, Mishinov SV, Proskurina AS, Potter EA, Efremov YR, Bayborodin SI, Tyrinova TV, Stupak VV, Ostatin AA, Chernykh ER, Bogachev SS.

Technol Cancer Res Treat. 2018 Jan 1;17:1533034617753812. doi: 10.1177/1533034617753812.

12.

Experimental Study of Yeast RNA Preparation as a Possible Radioprotective Agent for Radiotherapy of Malignant Tumors.

Nikolin VP, Bogachev SS, Popova NA, Tornuev YV, Vinogradova EV.

Bull Exp Biol Med. 2017 Sep;163(5):639-642. doi: 10.1007/s10517-017-3868-x. Epub 2017 Sep 25.

PMID:
28948545
13.

Spherically symmetric volume elements as basis functions for image reconstructions in computed laminography.

Trampert P, Vogelgesang J, Schorr C, Maisl M, Bogachev S, Marniok N, Louis A, Dahmen T, Slusallek P.

J Xray Sci Technol. 2017 Mar 21. doi: 10.3233/XST-16230. [Epub ahead of print]

PMID:
28339423
14.

Gene expression profiling of tumor-initiating stem cells from mouse Krebs-2 carcinoma using a novel marker of poorly differentiated cells.

Potter EA, Dolgova EV, Proskurina AS, Efremov YR, Minkevich AM, Rozanov AS, Peltek SE, Nikolin VP, Popova NA, Seledtsov IA, Molodtsov VV, Zavyalov EL, Taranov OS, Baiborodin SI, Ostanin AA, Chernykh ER, Kolchanov NA, Bogachev SS.

Oncotarget. 2017 Feb 7;8(6):9425-9441. doi: 10.18632/oncotarget.14116.

15.

Nonadherent Spheres With Multiple Myeloma Surface Markers Contain Cells that Contribute to Sphere Formation and Are Capable of Internalizing Extracellular Double-Stranded DNA.

Dolgova EV, Shevela EY, Tyrinova TV, Minkevich AM, Proskurina AS, Potter EA, Orishchenko KE, Zavjalov EL, Bayborodin SI, Nikolin VP, Popova NA, Pronkina NV, Ostanin AA, Chernykh ER, Bogachev SS.

Clin Lymphoma Myeloma Leuk. 2016 Oct;16(10):563-576. doi: 10.1016/j.clml.2016.06.014. Epub 2016 Jun 23.

PMID:
27431933
16.

Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen.

Proskurina AS, Gvozdeva TS, Potter EA, Dolgova EV, Orishchenko KE, Nikolin VP, Popova NA, Sidorov SV, Chernykh ER, Ostanin AA, Leplina OY, Dvornichenko VV, Ponomarenko DM, Soldatova GS, Varaksin NA, Ryabicheva TG, Uchakin PN, Rogachev VA, Shurdov MA, Bogachev SS.

BMC Cancer. 2016 Aug 18;16:651. doi: 10.1186/s12885-016-2711-5.

17.

Lymph cytokines as markers oncogenesis and effective treatment of experimental breast cancer Wistar rat.

Poveshchenko AF, Kazakov OV, Orlov NB, Poveshchenko OV, Kim II, Bondarenko NA, Solovieva IG, Strunkin DN, Kabakov AV, Rayter TV, Lykov AP, Bogachev SS, Pokushalov EA, Konenkov VI.

Patol Fiziol Eksp Ter. 2016 Jul-Sep;60(3):68-75.

PMID:
29244910
18.

Properties of internalization factors contributing to the uptake of extracellular DNA into tumor-initiating stem cells of mouse Krebs-2 cell line.

Dolgova EV, Potter EA, Proskurina AS, Minkevich AM, Chernych ER, Ostanin AA, Efremov YR, Bayborodin SI, Nikolin VP, Popova NA, Kolchanov NA, Bogachev SS.

Stem Cell Res Ther. 2016 May 25;7(1):76. doi: 10.1186/s13287-016-0338-8.

19.

Advanced materials for multilayer mirrors for extreme ultraviolet solar astronomy.

Bogachev SA, Chkhalo NI, Kuzin SV, Pariev DE, Polkovnikov VN, Salashchenko NN, Shestov SV, Zuev SY.

Appl Opt. 2016 Mar 20;55(9):2126-35. doi: 10.1364/AO.55.002126.

PMID:
27140543
20.

Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.

Proskurina AS, Gvozdeva TS, Alyamkina EA, Dolgova EV, Orishchenko KE, Nikolin VP, Popova NA, Sidorov SV, Chernykh ER, Ostanin AA, Leplina OY, Dvornichenko VV, Ponomarenko DM, Soldatova GS, Varaksin NA, Ryabicheva TG, Uchakin PN, Zagrebelniy SN, Rogachev VA, Bogachev SS, Shurdov MA.

BMC Cancer. 2016 Feb 17;16:117. doi: 10.1186/s12885-016-2163-y. No abstract available.

21.

A strategy to eradicate well-developed Krebs-2 ascites in mice.

Potter EA, Dolgova EV, Proskurina AS, Minkevich AM, Efremov YR, Taranov OS, Omigov VV, Nikolin VP, Popova NA, Bayborodin SI, Ostanin AA, Chernykh ER, Kolchanov NA, Shurdov MA, Bogachev SS.

Oncotarget. 2016 Mar 8;7(10):11580-94. doi: 10.18632/oncotarget.7311.

22.

The Ettention software package.

Dahmen T, Marsalek L, Marniok N, Turoňová B, Bogachev S, Trampert P, Nickels S, Slusallek P.

Ultramicroscopy. 2016 Feb;161:110-118. doi: 10.1016/j.ultramic.2015.10.012. Epub 2015 Oct 17.

PMID:
26686659
23.

Marker Detection in Electron Tomography: A Comparative Study.

Trampert P, Bogachev S, Marniok N, Dahmen T, Slusallek P.

Microsc Microanal. 2015 Dec;21(6):1591-1601. Epub 2015 Nov 25.

PMID:
26601573
24.

Comparative analysis of pathologic processes developing in mice housed in SPF vs non-SPF conditions and treated with cyclophosphamide and dsDNA preparation.

Dolgova EV, Efremov YR, Taranov OS, Potter EA, Nikolin VP, Popova NA, Omigov VV, Chernykh ER, Proskurina AS, Bogachev SS.

Pathol Res Pract. 2015 Oct;211(10):754-8. doi: 10.1016/j.prp.2015.07.002. Epub 2015 Jul 6.

PMID:
26293796
25.

Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.

Proskurina AS, Gvozdeva TS, Alyamkina EA, Dolgova EV, Orishchenko KE, Nikolin VP, Popova NA, Sidorov SV, Chernykh ER, Ostanin AA, Leplina OY, Dvornichenko VV, Ponomarenko DM, Soldatova GS, Varaksin NA, Ryabicheva TG, Uchakin PN, Zagrebelniy SN, Rogachev VA, Bogachev SS, Shurdov MA.

BMC Cancer. 2015 Mar 13;15:122. doi: 10.1186/s12885-015-1142-z. Erratum in: BMC Cancer. 2016;16:117. Uchakin, Peter N [added].

26.

Combination of cyclophosphamide and double-stranded DNA demonstrates synergistic toxicity against established xenografts.

Alyamkina EA, Nikolin VP, Popova NA, Minkevich AM, Kozel AV, Dolgova EV, Efremov YR, Bayborodin SI, Andrushkevich OM, Taranov OS, Omigov VV, Rogachev VA, Proskurina AS, Vereschagin EI, Kiseleva EV, Zhukova MV, Ostanin AA, Chernykh ER, Bogachev SS, Shurdov MA.

Cancer Cell Int. 2015 Mar 19;15:32. doi: 10.1186/s12935-015-0180-6. eCollection 2015.

27.

Identification of cancer stem cells and a strategy for their elimination.

Dolgova EV, Alyamkina EA, Efremov YR, Nikolin VP, Popova NA, Tyrinova TV, Kozel AV, Minkevich AM, Andrushkevich OM, Zavyalov EL, Romaschenko AV, Bayborodin SI, Taranov OS, Omigov VV, Shevela EY, Stupak VV, Mishinov SV, Rogachev VA, Proskurina AS, Mayorov VI, Shurdov MA, Ostanin AA, Chernykh ER, Bogachev SS.

Cancer Biol Ther. 2014 Oct;15(10):1378-94. doi: 10.4161/cbt.29854.

28.

Cytotoxic activity of ex-vivo generated IFNα-induced monocyte-derived dendritic cells in brain glioma patients.

Tyrinova TV, Leplina OY, Mishinov SV, Tikhonova MA, Shevela EY, Stupak VV, Pendyurin IV, Shilov AG, Alyamkina EA, Rubtsova NV, Bogachev SS, Ostanin AA, Chernykh ER.

Cell Immunol. 2013 Jul-Aug;284(1-2):146-53. doi: 10.1016/j.cellimm.2013.07.013. Epub 2013 Aug 2.

PMID:
23973877
29.

Delivery and processing of exogenous double-stranded DNA in mouse CD34+ hematopoietic progenitor cells and their cell cycle changes upon combined treatment with cyclophosphamide and double-stranded DNA.

Dolgova EV, Efremov YR, Orishchenko KE, Andrushkevich OM, Alyamkina EA, Proskurina AS, Bayborodin SI, Nikolin VP, Popova NA, Chernykh ER, Ostanin AA, Taranov OS, Omigov VV, Minkevich AM, Rogachev VA, Bogachev SS, Shurdov MA.

Gene. 2013 Oct 10;528(2):74-83. doi: 10.1016/j.gene.2013.06.058. Epub 2013 Jul 30.

PMID:
23911305
30.

Effects of human exogenous DNA on production of perforin-containing CD8+ cytotoxic lymphocytes in laboratory setting and clinical practice.

Alyamkina EA, Leplina OY, Ostanin AA, Chernykh ER, Nikolin VP, Popova NA, Proskurina AS, Gvozdeva TS, Dolgova EV, Orishchenko KE, Rogachev VA, Sidorov SV, Varaksin NA, Ryabicheva TG, Bogachev SS, Shurdov MA.

Cell Immunol. 2012 Mar-Apr;276(1-2):59-66. doi: 10.1016/j.cellimm.2012.04.004. Epub 2012 Apr 7.

PMID:
22578800
31.

"Delayed death" phenomenon: a synergistic action of cyclophosphamide and exogenous DNA.

Dolgova EV, Proskurina AS, Nikolin VP, Popova NA, Alyamkina EA, Orishchenko KE, Rogachev VA, Efremov YR, Dubatolova TD, Prokopenko AV, Chernykh ER, Ostanin AA, Taranov OS, Omigov VV, Zagrebelniy SN, Bogachev SS, Shurdov MA.

Gene. 2012 Mar 10;495(2):134-45. doi: 10.1016/j.gene.2011.12.032. Epub 2011 Dec 27.

PMID:
22227496
32.

A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation.

Alyamkina EA, Nikolin VP, Popova NA, Dolgova EV, Proskurina AS, Orishchenko KE, Efremov YR, Chernykh ER, Ostanin AA, Sidorov SV, Ponomarenko DM, Zagrebelniy SN, Bogachev SS, Shurdov MA.

Genet Vaccines Ther. 2010 Nov 1;8:7. doi: 10.1186/1479-0556-8-7.

33.

Effect of double-stranded DNA on maturation of dendritic cells in vitro.

Alyamkina EA, Leplina OY, Sakhno LV, Chernykh ER, Ostanin AA, Efremov YR, Shilov AG, Proskurina AS, Orishchenko KE, Dolgova EV, Rogachev VA, Nikolin VP, Popova NA, Zagrebelniy SN, Bogachev SS, Shurdov MA.

Cell Immunol. 2010;266(1):46-51. doi: 10.1016/j.cellimm.2010.08.011. Epub 2010 Sep 21.

PMID:
20863487
34.

Exogenous allogenic fragmented double-stranded DNA is internalized into human dendritic cells and enhances their allostimulatory activity.

Alyamkina EA, Dolgova EV, Likhacheva AS, Rogachev VA, Sebeleva TE, Nikolin VP, Popova NA, Kiseleva EV, Orishchenko KE, Sakhno LV, Gel'fgat EL, Ostanin AA, Chernykh ER, Zagrebelniy SN, Bogachev SS, Shurdov MA.

Cell Immunol. 2010;262(2):120-6. doi: 10.1016/j.cellimm.2010.01.005. Epub 2010 Feb 1.

PMID:
20170907
35.

Combined therapy with cyclophosphamide and DNA preparation inhibits the tumor growth in mice.

Alyamkina EA, Dolgova EV, Likhacheva AS, Rogachev VA, Sebeleva TE, Nikolin VP, Popova NA, Orishchenko KE, Strunkin DN, Chernykh ER, Zagrebelniy SN, Bogachev SS, Shurdov MA.

Genet Vaccines Ther. 2009 Aug 14;7:12. doi: 10.1186/1479-0556-7-12.

36.

[Protamine association with exogenous DNA's versus its ability to inhibit experimental tumors].

Aliamkina EA, Likhacheva AS, Nikolin VP, Popova NA, Dolgova EV, Rogachev VA, Sebeleva TE, Strunkin DN, Bogachev SS, Shudrov MA.

Vopr Onkol. 2009;55(6):765-8. Russian.

PMID:
20210023
37.

[Leukocyte stimulation by DNA fragments shored up protamine in cyclophosphamide-induced leukopoiesis in mice].

Dolgova EV, Rogachev VA, Nikolin VP, Popova NA, Likhacheva AS, Aliamkina EA, Sebeleva TE, Chernykh ER, Gel'fgat EL, Bogachev SS, Shudrov MA.

Vopr Onkol. 2009;55(6):761-4. Russian.

PMID:
20210022
38.

Natural human gene correction by small extracellular genomic DNA fragments.

Yakubov LA, Rogachev VA, Likhacheva AC, Bogachev SS, Sebeleva TE, Shilov AG, Baiborodin SI, Petrova NA, Mechetina LV, Shurdov MA, Wickstrom E.

Cell Cycle. 2007 Sep 15;6(18):2293-301. Epub 2007 Jul 12.

PMID:
17703110
39.

[Effect of exogenous dna injection on leukopoietic repair and antitumor action of cyclophosphamide].

Nikolin VP, Popova NA, Sebeleva TE, Strunkin DN, Rogachev VA, Semenov DV, Bogachev SS, Iakubov LA, Shurdov MA.

Vopr Onkol. 2006;52(3):336-40. Russian.

PMID:
17191708
40.

Qualitative and quantitative characteristics of the extracellular DNA delivered to the nucleus of a living cell.

Rogachev VA, Likhacheva A, Vratskikh O, Mechetina LV, Sebeleva TE, Bogachev SS, Yakubov LA, Shurdov MA.

Cancer Cell Int. 2006 Oct 11;6:23.

41.

[Effect of exogenous DNA on the growth of transplantable tumors].

Nikolin VP, Popova NA, Sebeleva TE, Strunkin DN, Rogachev VA, Semënov DV, Bogachev SS, Iakubov LA, Shurdov MA.

Vopr Onkol. 2006;52(1):66-9. Russian.

PMID:
16715707
42.

[A combined approach to mapping the proximal border of the right arm of polytene chromosome 2 in Drosophila melanogaster otu 11].

Boĭkova TV, Sharakhov IV, Kopyl SA, Volkova E, Fisher PA, Rogachev VA, Sebeleva TE, Bogachev SS.

Tsitologiia. 2005;47(3):249-54. Russian.

PMID:
16706170
43.

[Specific DNA sequences are associated with nuclear envelopes of pseudonurse cells in Drosophila melanogaster otu 11].

Sharakhov IV, Baricheva EM, Bogachev SS, Fisher PA, Lapik ER, Rogachev VA, Sebeleva TE.

Tsitologiia. 2005;47(3):243-8. Russian.

PMID:
16706169
44.

[The M/SAR elements of the bithorax complex in Drosophila melanogaster].

Boĭkova TV, Orlando V, Lupo R, Bogachev SS.

Genetika. 2005 Nov;41(11):1467-79. Russian.

PMID:
16358714
45.

Changes in the symptoms of hypothalamic diabetes insipidus after treatment with homologous exogenous DNA.

Khegai II, Bogachev SS, Os'kina IN, Popova NA, Semenov DV, Shurdov MA, Yakubov LA.

Dokl Biol Sci. 2004 May-Jun;396:233-5. No abstract available.

PMID:
15354835
46.

Lamins and their functions in cell cycle.

Likhacheva EV, Bogachev SS.

Membr Cell Biol. 2001 Jul;14(5):565-77. Review.

PMID:
11699861
47.

[Dynamics of chromatin position within the interphase nucleus].

Bogachev SS, Likhacheva EV, Borisevich IV, Kokoza EB.

Ontogenez. 2000 Jul-Aug;31(4):243-50. Review. Russian.

PMID:
10984899
48.

In vivo association of lamins with nucleic acids in Drosophila melanogaster.

Rzepecki R, Bogachev SS, Kokoza E, Stuurman N, Fisher PA.

J Cell Sci. 1998 Jan;111 ( Pt 1):121-9.

49.

[Structure of blocks of pericentromeric heterochromatin at chromosomes 3 and 4 in pseudonurse cells from larvae of Drosophila melanogaster line OTU].

Sharakhov IV, Stegniĭ VN, Bogachëv SS, Baricheva EM, Lapik ER, Fisher PA.

Dokl Akad Nauk. 1997 Mar;353(2):281-3. Russian. No abstract available.

PMID:
9244494
50.

[Chromosomal localization of M/SAR from DNA of the clone lambda20p1.4 in Drosophila melanogaster salivary glands].

Sharakhov IV, Bogachev SS, Fisher PA.

Genetika. 1997 Feb;33(2):277-80. Russian.

PMID:
9162706

Supplemental Content

Loading ...
Support Center